Pure Global AI
NCT06266403Not yet recruiting

Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications

Penn State UniversityClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Amyotrophic Lateral Sclerosis
Drug/Device/Intervention
Structured Communicative Interaction
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Penn State University
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Mar 01, 2029
Enrollment
300 participants
Primary outcome

Formant frequencies of speech sounds,Intelligibility of recorded speech,Syntactic properties,Pragmatic Properties,Duration of speech sounds

Summary

The goal of this clinical trial is to learn about the effect of communicative interaction on
 verbal communication in people with amyotrophic lateral sclerosis (ALS) and age-matched
 speakers.
 
 The question is, What are the effects of communicative interaction on verbal communication in
 people with ALS?
 
 Participants will read words and sentences while they are in a solo setting and interactive
 setting.

ICD-10 classifications
Neuralgic amyotrophyMotor neuron diseaseOther degenerative diseases of the nervous systemOther degenerative disorders of nervous system in diseases classified elsewhereMultiple sclerosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06266403
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06266403 through Pure Global AI's free database. This phase not specified trial is sponsored by Penn State University and is currently Not yet recruiting. The study focuses on Amyotrophic Lateral Sclerosis. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.